Liraglutide Improves Non-Alcoholic Fatty Liver Disease In Diabetic Mice By Modulating Inflammatory Signaling Pathways

• Main Authors: Luo Y (Author), Yang P (Author), Li Z (Author), Shen J (Author), Li R (Author), Zheng H (Author), Liang Y (Author), Xia N (Author)
• Format: Book
• Published: Dove Medical Press, 2019-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Ying Luo,1,* Pijian Yang,1,* Zhengming Li,2 Yunchen Luo,2 Jing Shen,1 Ruwen Li,1 Hua Zheng,3 Yuzhen Liang,2 Ning Xia1 1Department of Endocrinology and Metabolism, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, People’s Republic of China; 2Department of Endocri...